Lisocabtagene maraleucel Intravenous Advanced Patient Information - Drugs.com

Skip to main content
Print
Save

# Lisocabtagene maraleucel (Intravenous)

Medically reviewed by Drugs.com. Last updated on Jul 12, 2022.

Intravenous route(Suspension)

Warning: Cytokine Release Syndrome and Neurologic ToxicitiesCytokine release syndrome (CRS), including fatal or life-threatening reactions, occurred in patients receiving lisocabtagene maraleucel. Do not administer lisocabtagene maraleucel to patients with active infection or inflammatory disorders. Treat severe or life-threatening CRS with tocilizumab with or without corticosteroids.Neurologic toxicities, including fatal or life-threatening reactions, occurred in patients receiving lisocabtagene maraleucel, including concurrently with CRS, after CRS resolution, or in the absence of CRS. Monitor for neurological events after treatment with lisocabtagene maraleucel. Provide supportive care and/or corticosteroids as needed.Lisocabtagene maraleucel is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the Breyanzi(R) REMS .

## Commonly used brand name(s)

In the U.S.

- Breyanzi

Available Dosage Forms:

- Suspension

Therapeutic Class: Antineoplastic Agent

Chemical Class: CAR T-Cell Agent

## Uses for lisocabtagene maraleucel

Lisocabtagene maraleucel injection is used to treat large B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL), high grade B-cell lymphoma, primary mediastinal large B-cell lymphoma, and follicular lymphoma grade 3B that has come back (relapsed) or did not respond to the treatment (refractory) in patients who have received at least 2 previous treatments that did not work well.

Lisocabtagene maraleucel is an antineoplastic (cancer) medicine that is made from your own white blood cells, which have been modified to recognize and attack your cancer cells. Before you begin treatment, talk to your doctor about the benefits of lisocabtagene maraleucel as well as the possible risks of receiving it.

Lisocabtagene maraleucel is available only under a restricted distribution program called Breyanzi® REMS (Risk Evaluation and Mitigation Strategy) Program.

## Before using lisocabtagene maraleucel

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For lisocabtagene maraleucel, the following should be considered:

### Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to lisocabtagene maraleucel or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

### Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of lisocabtagene maraleucel injection in the pediatric population. Safety and efficacy have not been established.

### Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of lisocabtagene maraleucel injection in the elderly.

### Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

### Interactions with medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

### Interactions with food/tobacco/alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

### Other medical problems

The presence of other medical problems may affect the use of lisocabtagene maraleucel. Make sure you tell your doctor if you have any other medical problems, especially:

- Heart problems or
- Heart rhythm problems (eg, arrhythmia, tachycardia) or
- Hypotension (low blood pressure) or
- Infections (including hepatitis B), active or history of or
- Kidney disease or
- Seizures, history of or
- Stroke, history of—Use with caution. May cause side effects to become worse.

## Related/similar drugs

prednisone, rituximab, cyclophosphamide, doxorubicin, Rituxan, vincristine, Breyanzi

## Proper use of lisocabtagene maraleucel

A nurse or other trained health professional will give you lisocabtagene maraleucel in a medical facility. It is given through a needle placed into one of your veins using a pump. The medicine must be injected slowly, so your IV tube will need to stay in place for at least 15 minutes. It is given 2 to 7 days after completing treatment with other cancer medicines (eg, fludarabine, cyclophosphamide).

You may also receive other medicines (eg, allergy medicine, fever medicine) 30 to 60 minutes before starting treatment with lisocabtagene maraleucel.

Your doctor will check you for unwanted effects at least daily for 7 days. Your doctor will also want you to stay close to the hospital or center for at least 4 weeks after your infusion.

It is very important that you understand the requirements of the Breyanzi® REMS program, and become familiar with the Breyanzi® medication guide. Read and follow these instructions carefully. Ask your doctor if you have any questions.

### Missed dose

Lisocabtagene maraleucel needs to be given on a fixed schedule. If you miss a dose, call your doctor, home health caregiver, or treatment clinic for instructions.

Detailed Lisocabtagene maraleucel dosage information

## Precautions while using lisocabtagene maraleucel

It is very important that your doctor check your progress at regular visits to make sure that lisocabtagene maraleucel is working properly. Blood tests are needed to check for unwanted effects.

If you are a woman who can get pregnant, your doctor may do tests to make sure you are not pregnant before starting treatment.

Lisocabtagene maraleucel may cause cytokine release syndrome (CRS), which may be life-threatening and requires immediate attention. Tell your doctor right away if you have fever, chills, headache, nausea, lightheadedness, dizziness, fainting, skin rash, trouble breathing, or tiredness or weakness.

Check with your doctor right away if you have seizures, loss of balance, loss of consciousness, confusion, disorientation, difficulty with speaking, or slurred speech. These could be symptoms of a serious nerve problem.

Lisocabtagene maraleucel may cause serious allergic reactions, including anaphylaxis, which may be life-threatening and require immediate medical attention. Check with your doctor right away if you have a rash, itching, dizziness, fainting, fast heartbeat, trouble breathing or swallowing, or chest tightness while you are using lisocabtagene maraleucel.

Lisocabtagene maraleucel lowers the number of some types of blood cells in your body. Because of this, you may bleed or get infections more easily. To help with these problems, avoid being near people who are sick or have infections. Wash your hands often. Stay away from rough sports or other situations where you could be bruised, cut, or injured. Brush and floss your teeth gently. Be careful when using sharp objects, including razors and fingernail clippers.

Lisocabtagene maraleucel may increase your risks for hypogammaglobulinemia (immune system problem) and getting other cancers. Talk to your doctor if you have questions about these risks.

While you are being treated with lisocabtagene maraleucel injection, do not have any immunizations (vaccinations) without your doctor's approval. Live virus vaccinations should not be given for at least 6 weeks before start of treatment, during treatment, and until recovery following the last cycle of lisocabtagene maraleucel.

Lisocabtagene maraleucel may cause dizziness, confusion, seizures, or decreased alertness. Do not drive or do anything else that could be dangerous until you know how lisocabtagene maraleucel affects you, for at least 8 weeks after treatment.

Before you have any medical tests, tell the medical doctor in charge that you are taking lisocabtagene maraleucel. The results of some tests may be affected by lisocabtagene maraleucel.

## Lisocabtagene maraleucel side effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur:

More common

- Agitation
- back pain
- bleeding gums
- bloody urine
- blurred vision
- body aches or pain
- burning, numbness, tingling, or painful sensations
- chest pain
- chills
- coma
- confusion
- cough
- coughing up blood
- decrease frequency or amount of urine
- diarrhea
- difficulty swallowing
- dizziness
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- drowsiness
- ear congestion
- fast, pounding, or irregular heartbeat or pulse
- fever
- hallucinations
- headache
- hives, itching
- holding false beliefs that cannot be changed by fact
- increased menstrual flow or vaginal bleeding
- increased thirst
- irritability
- loss of appetite
- loss of voice
- lower back or side pain
- mood or mental changes
- muscle or bone pain
- muscle spasm, tenderness, twitching, jerking, wasting, or weakness
- nausea
- nosebleeds
- painful or difficult urination
- paralysis
- pounding in the ears
- problems with speech or speaking
- prolonged bleeding from cuts
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- red or black, tarry stools
- red or dark brown urine
- runny or stuffy nose
- seizures
- shakiness and unsteady walk
- shakiness in the legs, arms, hands, or feet
- skin rash
- slow or fast heartbeat
- sneezing
- sore throat
- stiff neck
- stomach pain
- sweating
- trembling and shaking of the hands or feet
- trouble breathing
- ulcers, sores, or white spots in the mouth
- unsteadiness, awkwardness, trembling, or other problems with muscle control or coordination
- unusual bleeding or bruising
- unusual excitement, nervousness, or restlessness
- unusual tiredness or weakness
- vomiting
- weight gain

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

- Constipation
- tenderness, pain, swelling, warmth, skin discoloration, and prominent superficial veins at the injection site
- trouble sleeping

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Lisocabtagene maraleucel side effects (more detail)

## More about lisocabtagene maraleucel

- Check interactions
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- En español

### Patient resources

- Drug Information

#### Other brands

Breyanzi

### Related treatment guides

- B Cell Lymphoma
- Diffuse Large B-Cell Lymphoma

## Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer